419 related articles for article (PubMed ID: 19453623)
1. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).
Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
Clin Endocrinol (Oxf); 2010 Jan; 72(1):70-5. PubMed ID: 19453623
[TBL] [Abstract][Full Text] [Related]
2. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
Correa-Silva SR; Nascif SO; Lengyel AM
Pituitary; 2006; 9(2):101-7. PubMed ID: 16832586
[TBL] [Abstract][Full Text] [Related]
3. Partial restoration of GH responsiveness to ghrelin in Cushing's disease after 6 months of ketoconazole treatment: comparison with GHRP-6 and GHRH.
Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
Eur J Endocrinol; 2009 Nov; 161(5):681-6. PubMed ID: 19696160
[TBL] [Abstract][Full Text] [Related]
4. Effect of one month ketoconazole treatment on GH, cortisol and ACTH release after ghrelin, GHRP-6 and GHRH administration in patients with Cushing's disease.
Correa-Silva SR; Nascif SO; Silva MR; Molica P; Lengyel AM
Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1110-7. PubMed ID: 18157387
[TBL] [Abstract][Full Text] [Related]
5. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus.
de Sá LB; Nascif SO; Correa-Silva SR; Molica P; Vieira JG; Dib SA; Lengyel AM
Metabolism; 2010 Oct; 59(10):1536-42. PubMed ID: 20189610
[TBL] [Abstract][Full Text] [Related]
6. GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP.
Oliveira JH; Vieira JG; Abucham J; Lengyel AM
J Endocrinol Invest; 2003 Mar; 26(3):230-5. PubMed ID: 12809173
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas.
Cannavò S; Almoto B; Dall'Asta C; Corsello S; Lovicu RM; De Menis E; Trimarchi F; Ambrosi B
Eur J Endocrinol; 2003 Sep; 149(3):195-200. PubMed ID: 12943521
[TBL] [Abstract][Full Text] [Related]
8. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
9. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.
Arvat E; Giordano R; Ramunni J; Arnaldi G; Colao A; Deghenghi R; Lombardi G; Mantero F; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1998 Dec; 83(12):4207-11. PubMed ID: 9851753
[TBL] [Abstract][Full Text] [Related]
10. Association between tumoral GH-releasing peptide receptor type 1a mRNA expression and in vivo response to GH-releasing peptide-6 in ACTH-dependent Cushing's syndrome patients.
Machado MC; Valeria de Sa S; Correa-Giannella ML; Giorgi RR; Pereira MA; Cescato VA; Giannella-Neto D; Salgado LR
Eur J Endocrinol; 2008 May; 158(5):605-13. PubMed ID: 18426818
[TBL] [Abstract][Full Text] [Related]
11. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.
Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR
J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses.
Leal-Cerro A; Torres E; Soto A; Dios E; Deghenghi R; Arvat E; Ghigo E; Dieguez C; Casanueva FF
Neuroendocrinology; 2002 Dec; 76(6):390-6. PubMed ID: 12566947
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin stimulates adrenocorticotrophic hormone (ACTH) secretion by human ACTH-secreting pituitary adenomas in vitro.
Pecori Giraldi F; Bucciarelli LG; Saccani A; Scacchi M; Pesce S; Losa M; Cavagnini F
J Neuroendocrinol; 2007 Mar; 19(3):208-12. PubMed ID: 17280594
[TBL] [Abstract][Full Text] [Related]
14. The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease.
Giordano R; Picu A; Pagotto U; De Iasio R; Bonelli L; Prodam F; Broglio F; Marafetti L; Pasquali R; Maccario M; Ghigo E; Arvat E
Eur J Endocrinol; 2005 Oct; 153(4):535-43. PubMed ID: 16189175
[TBL] [Abstract][Full Text] [Related]
15. Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease.
Arvat E; Ramunni J; Giordano R; Maccagno B; Broglio F; Benso A; Deghenghi R; Ghigo E
J Endocrinol Invest; 1999 Jan; 22(1):23-8. PubMed ID: 10090133
[TBL] [Abstract][Full Text] [Related]
16. ACTH response to corticotropin releasing hormone in Cushing's disease before and after ketoconazole: in vivo and in vitro studies.
Boscaro M; Sonino N; Rampazzo A; Menegus AM; Mantero F
Horm Metab Res Suppl; 1987; 16():60-2. PubMed ID: 2832292
[TBL] [Abstract][Full Text] [Related]
17. Use of ketoconazole in the treatment of Cushing's syndrome.
Loli P; Berselli ME; Tagliaferri M
J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
19. Combined Administration of Ghrelin and Corticotropin-Releasing Hormone in the Diagnosis of Cushing's Disease.
Miljić D; Polovina S; Doknić M; Pekić S; Stojanović M; Petakov M; Micić D; Popović V
Neuroendocrinology; 2017; 104(1):33-39. PubMed ID: 26836811
[TBL] [Abstract][Full Text] [Related]
20. Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease.
Grottoli S; Arvat E; Gauna C; Maccagno B; Ramunni J; Giordano R; Maccario M; Deghenghi R; Ghigo E
Pituitary; 1999 Nov; 2(3):197-204. PubMed ID: 11081154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
